Company Description
Selectis Health, Inc. (GBCS) is a healthcare company that owns and/or operates medical care facilities in the United States. According to company disclosures, Selectis Health focuses on healthcare facilities in Arkansas, Georgia, Ohio, and Oklahoma, with an emphasis on skilled nursing, assisted living, independent living, and related rehabilitation and healthcare services. Its shares trade on the OTC market under the symbol GBCS.
Business focus and facility footprint
Based on recent company announcements, Selectis Health’s footprint centers on skilled nursing facilities, assisted living, and independent living communities. The company has disclosed that its facilities provide living services, speech therapy, occupational therapy, physical therapy, social services, and other rehabilitation and healthcare services. These services are delivered across multiple states, with a focus on the American Southcentral and Southeastern regions.
In various press releases, Selectis Health has summarized its facility footprint at different points in time. Its facilities have included skilled nursing centers in Arkansas, Georgia, Ohio, and Oklahoma, as well as an assisted living facility and an independent living community on a shared campus in Tulsa, Oklahoma. Some facilities are owned and operated directly by Selectis Health or its wholly owned subsidiaries, while others are leased facilities operated by third parties, as indicated in the company’s disclosures.
Strategic emphasis and regional relationships
According to the company’s own description, Selectis Health focuses on building strategic relationships with the local communities in which its facilities are located. The company states that these partnerships are intended to improve the quality of care for facility residents. It has also described a focused growth strategy aimed at deepening its presence in Southcentral and Southeastern U.S. markets to better serve an aging population along a continuum of care that includes skilled nursing, assisted living, and independent living.
Company communications highlight efforts to improve facility operations, patient census, and quality measurement ratings. For example, Selectis Health has discussed operational improvement initiatives at facilities such as Southern Hills in Tulsa, Oklahoma and Park Place in Oklahoma City, Oklahoma, including upgrades to building infrastructure, development of independent living communities, and changes in facility management. The company has also reported improvements in quality measurement ratings as measured by the Centers for Medicare & Medicaid Services (CMS) across certain facilities, including facilities in Georgia and Oklahoma.
Portfolio optimization and real estate transactions
Selectis Health has described an ongoing effort to optimize its facility footprint through real estate transactions. In multiple press releases and Form 8-K filings, the company has reported entering into and completing purchase and sale agreements for certain skilled nursing facilities in Georgia. These transactions have involved the sale of real estate, buildings, improvements, and certain personal property used in facility operations, and in some cases have been accompanied by operations transfer agreements to new operators.
For example, the company has disclosed agreements to sell four skilled nursing facilities in Georgia for an aggregate consideration of $31 million, as well as a separate agreement and subsequent closing for the sale of the Archway Transitional Care Center in Macon, Georgia. In a later announcement, Selectis Health reported a definitive purchase and sale agreement for two additional Georgia skilled nursing facilities, known as Providence of Sparta Health & Rehab and Warrenton Health & Rehabilitation. The company has stated that proceeds from such transactions are expected to enhance its balance sheet, retire existing debt, and provide flexibility in optimizing its remaining facility footprint, although it also notes that completion of pending transactions is subject to customary closing conditions and regulatory approvals.
Operational initiatives and quality measures
Company updates have described various operational initiatives, including efforts to increase patient census, adjust patient mix, and manage costs. Selectis Health has discussed the use of group purchasing organizations (GPOs) and enterprise purchasing software to seek cost savings across its facilities. It has also highlighted internal training programs and facility-level leadership hires intended to support operational efficiency and communication.
In its communications, Selectis Health has emphasized improvements in occupancy and quality at specific facilities. For instance, the company has reported increases in occupancy at its Southern Hills campus in Tulsa and at the Park Place facility in Oklahoma City. It has also referenced improvements in CMS quality measurement ratings at facilities in Georgia and Oklahoma, and has described these ratings as a public scorecard reflecting regulatory compliance, staffing stability, and resident outcomes.
Corporate structure and governance context
Selectis Health, Inc. is incorporated in Utah, as reflected in its SEC filings. The company has reported changes in its leadership and board composition over time through Current Reports on Form 8-K and press releases. These disclosures have included appointments of executive officers and directors, as well as changes in board membership and committee participation. The company has also noted efforts to meet corporate governance requirements associated with potential listing on a major national exchange, while its shares trade on the OTC market.
In addition, Selectis Health has reported entering into financing arrangements, including senior secured promissory notes and related modification agreements. For example, an 8-K filing describes a Third Amended and Restated Allonge and Modification Agreement that extends the maturity date and adjusts terms of certain senior secured promissory notes, and also references warrants previously granted to noteholders.
Geographic and sector positioning
According to its repeated "About Selectis Health" descriptions, the company positions itself within the healthcare sector as an owner and/or operator of healthcare facilities in Arkansas, Georgia, Ohio, and Oklahoma. Its stated focus is on serving the aging population in Southcentral and Southeastern U.S. markets through a continuum of care that includes skilled nursing, assisted living, independent living, and rehabilitation services. This places Selectis Health in the medical care facilities industry, with operations tied to long-term care, post-acute care, and related services.
Investor considerations
For investors researching GBCS stock, company press releases and SEC filings provide insight into Selectis Health’s facility portfolio, real estate transactions, financing arrangements, and governance changes. The company has discussed strategic priorities such as improving operational efficiency, optimizing its facility footprint, and managing its capital structure. Because many of these initiatives involve regulatory approvals, real estate transactions, and changes in facility operations, investors often review both news releases and formal filings to understand the company’s progress and obligations.
Frequently asked questions (FAQ)
Stock Performance
Selectis Health (GBCS) stock last traded at $4.00, down 0.90% from the previous close. Over the past 12 months, the stock has gained 82.0%. At a market capitalization of $12.4M, GBCS is classified as a micro-cap stock with approximately 3.1M shares outstanding.
Latest News
Selectis Health has 10 recent news articles, with the latest published 7 days ago. Of the recent coverage, 5 articles coincided with positive price movement and 1 with negative movement. Key topics include earnings, conferences. View all GBCS news →
SEC Filings
Selectis Health has filed 5 recent SEC filings, including 2 Form 8-K, 1 Form SC TO-T/A, 1 Form SC TO-T, 1 Form SC TO-C. The most recent filing was submitted on March 13, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all GBCS SEC filings →
Insider Radar
Insider buying activity at Selectis Health over the past 90 days may reflect management confidence in the company's direction. Institutional investors and analysts often monitor insider purchases as a potential bullish indicator for the stock.
Financial Highlights
Selectis Health generated $39.5M in revenue over the trailing twelve months, operating income reached -$2.7M (-6.9% operating margin), and net income was -$2.4M, reflecting a -6.1% net profit margin. Diluted earnings per share stood at $-0.80. The company generated -$1.8M in operating cash flow. With a current ratio of 0.18, short-term liquidity bears monitoring.
Upcoming Events
Tender offer expiration
Selectis Health has 1 upcoming scheduled event. The next event, "Tender offer expiration", is scheduled for May 11, 2026 (in 55 days). 1 of the upcoming events are financial in nature, such as earnings calls or quarterly results. Investors can track these dates to stay informed about potential catalysts that may affect the GBCS stock price.
Short Interest History
Short interest in Selectis Health (GBCS) currently stands at 261 shares, up 31.2% from the previous reporting period, representing 0.0% of the float. Over the past 12 months, short interest has increased by 31.2%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Selectis Health (GBCS) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed.
GBCS Company Profile & Sector Positioning
Selectis Health (GBCS) operates in the Medical Care Facilities industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing GBCS often look at related companies in the same sector, including Veltex (VLXC), Xcelerate Inc (XCRT), Revitalist Lifes (RVLWF), Healthlynked (HLYK), and Biocorrx Inc (BICX). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate GBCS's relative position within its industry.